Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
BMC Nephrol ; 21(1): 206, 2020 05 29.
Artículo en Inglés | MEDLINE | ID: mdl-32471386

RESUMEN

BACKGROUND: Previous study showed that purinergic P2X7 receptors (P2X7R) reach the highest expression in the first week after unilateral ureteral obstruction (UUO) in mice, and are involved in the process of inflammation, apoptosis and fibrosis of renal tissue. We, herein, document the role of purinergic P2X7 receptors activation on the third day of UUO, as assessed by means of BBG as its selective inhibitor. METHODS: We investigated the effects of brilliant blue G (BBG), a P2X7R antagonist, in the third day of kidney tissue response to UUO in rats. For this purpose, male Wistar rats submitted to UUO or sham operated, received BBG or vehicle (V), comprising four groups: UUO-BBG, UUO-V, sham-BBG and sham-V. The kidneys were harvested on day 3 UUO and prepared for histology, immunohistochemistry (P2X7R, PCNA, CD-68, α-sma, TGF-ß1, Heat-shock protein-47, TUNEL assay), quantitative real-time PCR (IL-1ß, procollagens type I, III, and IV) for mRNA quantification. RESULTS: The group UUO-V presented an enhancement in tubular cell P2X7-R expression, increase influx of macrophages and myofibroblasts, HSP-47 and TGF- ß1 expression. Also, upregulation of procollagen types I, III, and IV, and IL-1ß mRNAs were seen. On the other hand, group UUO-BBG showed lower expression of procollagens and IL-1ß mRNAs, as well as less immunoreactivity of HSP-47, TGF-ß, macrophages, myofibroblasts, and tubular apoptosis. This group also presented increased epithelial cell proliferation. CONCLUSION: BBG, a known highly selective inhibitor of P2X7R, attenuated renal inflammation, collagen synthesis, renal cell apoptosis, and enhanced renal cell proliferation in the early phase of rat model of UUO.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Riñón/patología , Nefritis/tratamiento farmacológico , Antagonistas del Receptor Purinérgico P2X/uso terapéutico , Colorantes de Rosanilina/uso terapéutico , Obstrucción Ureteral/complicaciones , Actinas/metabolismo , Animales , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Apoptosis/efectos de los fármacos , Movimiento Celular , Colágeno Tipo I/genética , Colágeno Tipo III/genética , Colágeno Tipo IV/genética , Fibrosis , Proteínas del Choque Térmico HSP47/metabolismo , Interleucina-1beta/genética , Riñón/metabolismo , Túbulos Renales/patología , Macrófagos/fisiología , Masculino , Miofibroblastos/fisiología , Nefritis/etiología , Antagonistas del Receptor Purinérgico P2X/farmacología , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Colorantes de Rosanilina/farmacología , Factores de Tiempo , Factor de Crecimiento Transformador beta1/metabolismo , Regulación hacia Arriba
2.
Sci Rep ; 9(1): 19604, 2019 12 20.
Artículo en Inglés | MEDLINE | ID: mdl-31862892

RESUMEN

Podocytes are specialized cells with a limited capacity for cell division that do not regenerate in response to injury and loss. Insults that compromise the integrity of podocytes promote proteinuria and progressive renal disease. The aim of this study was to evaluate the potential renoprotective and regenerative effects of mesenchymal stromal cells (mSC) in a severe form of the podocyte injury model induced by intraperitoneal administration of puromycin, aggravated by unilateral nephrectomy. Bone derived mSC were isolated and characterized according to flow cytometry analyses and to their capacity to differentiate into mesenchymal lineages. Wistar rats were divided into three groups: Control, PAN, and PAN+ mSC, consisting of PAN rats treated with 2 × 105 mSC. PAN rats developed heavy proteinuria, hypertension, glomerulosclerosis and significant effacement of the foot process. After 60 days, PAN rats treated with mSC presented a significant amelioration of all these abnormalities. In addition, mSC treatment recovered WT1 expression, improved nephrin, podocin, synaptopodin, podocalyxin, and VEGF expression, and downregulated proinflammatory Th1 cytokines in the kidney with a shift towards regulatory Th2 cytokines. In conclusion, mSC administration induced protection of podocytes in this experimental PAN model, providing new perspectives for the treatment of renal diseases associated with podocyte damage.


Asunto(s)
Enfermedades Renales/terapia , Células Madre Mesenquimatosas/citología , Podocitos/citología , Animales , Diferenciación Celular , División Celular , Regulación hacia Abajo , Glomeruloesclerosis Focal y Segmentaria/metabolismo , Glomeruloesclerosis Focal y Segmentaria/orina , Hipertensión , Inflamación , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Enfermedades Renales/inducido químicamente , Masculino , Proteínas de la Membrana/metabolismo , Proteínas de Microfilamentos/metabolismo , Nefrectomía , Podocitos/efectos de los fármacos , Proteinuria/orina , Puromicina Aminonucleósido , Ratas , Ratas Wistar , Regeneración , Sialoglicoproteínas/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo
3.
Nutrients ; 11(4)2019 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-31013737

RESUMEN

The innate immune response plays an important role in the pathophysiology of acute respiratory distress syndrome (ARDS). Glutamine (Gln) decreases lung inflammation in experimental ARDS, but its impact on the formation of extracellular traps (ETs) in the lung is unknown. In a mouse model of endotoxin-induced pulmonary ARDS, the effects of Gln treatment on leukocyte counts and ET content in bronchoalveolar lavage fluid (BALF), inflammatory profile in lung tissue, and lung morphofunction were evaluated in vivo. Furthermore, ET formation, reactive oxygen species (ROS) production, glutathione peroxidase (GPx), and glutathione reductase (GR) activities were tested in vitro. Our in vivo results demonstrated that Gln treatment reduced ET release (as indicated by cell-free-DNA content and myeloperoxidase activity), decreased lung inflammation (reductions in interferon-γ and increases in interleukin-10 levels), and improved lung morpho-function (decreased static lung elastance and alveolar collapse) in comparison with ARDS animals treated with saline. Moreover, Gln reduced ET and ROS formation in BALF cells stimulated with lipopolysaccharide in vitro, but it did not alter GPx or GR activity. In this model of endotoxin-induced pulmonary ARDS, treatment with Gln reduced pulmonary functional and morphological impairment, inflammation, and ET release in the lung.


Asunto(s)
Trampas Extracelulares/metabolismo , Glutamina/uso terapéutico , Inflamación/tratamiento farmacológico , Pulmón/efectos de los fármacos , Neumonía/tratamiento farmacológico , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Animales , ADN , Modelos Animales de Enfermedad , Endotoxinas , Femenino , Glutamina/farmacología , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Inflamación/etiología , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Recuento de Leucocitos , Pulmón/metabolismo , Pulmón/patología , Masculino , Ratones Endogámicos BALB C , Peroxidasa/metabolismo , Neumonía/etiología , Alveolos Pulmonares , Especies Reactivas de Oxígeno/metabolismo , Síndrome de Dificultad Respiratoria/metabolismo , Síndrome de Dificultad Respiratoria/patología
4.
Cell Physiol Biochem ; 41(5): 1736-1752, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28365681

RESUMEN

BACKGROUND/AIMS: We investigated the regenerative capacity of intravenous administration of bone marrow-derived mononuclear cells (BMMCs) in a rat model of bilateral renal ischemia/reperfusion (IR) injury and the involvement of inflammatory anti-inflammatory and other biological markers in this process. METHODS: Rats were subjected to 1h bilateral renal pedicle clamping. BMMCs were injected i.v 1h after reperfusion and tracked by 99mTc and GFP+ BMMCs. Twenty-four hours after reperfusion, renal function and histological changes were evaluated. The mRNA (real time PCR) and protein (ELISA and immuno-staining) expression of biological markers were analyzed. RESULTS: Renal function and structure improved after infusion of BMMCs in the IR group (IR-C). Labeled BMMCs were found in the kidneys after therapy. The expression of inflammatory and biological markers (TLR-2, TRL-4, RAGE, IL-17, HMGB-1, KIM-1) were reduced and the expression of anti-inflammatory and antioxidant markers (IL-10, Nrf2, and HO-1) were increased in IR-C animals compared with IR untreated animals (IR-S). The apoptotic index diminished and the proliferation index increased in IR-C compared with IR-S. CONCLUSION: The results contribute to our understanding of the role of different biological players in morphofunctional renal improvement and cytoprotection in a post-ischemic reperfusion kidney injury model subjected to cellular therapy.


Asunto(s)
Antioxidantes/metabolismo , Proteínas Reguladoras de la Apoptosis/metabolismo , Trasplante de Médula Ósea , Mediadores de Inflamación/metabolismo , Enfermedades Renales , Daño por Reperfusión , Aloinjertos , Animales , Biomarcadores/metabolismo , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/patología , Femenino , Inflamación/metabolismo , Inflamación/patología , Inflamación/terapia , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Enfermedades Renales/terapia , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Daño por Reperfusión/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...